Australia-wide express shipping · Free express shipping over $200 · AUD pricing shown before checkout

Research use only

Research-use-only peptide catalog.

Products are sold for in vitro research use only and are not for human or veterinary use. Review the catalog, shipping, and support information, then acknowledge when you are ready.

Research notes

CJC-1295 and Ipamorelin: Two Growth-Hormone Secretagogues Studied Together

A factual research-use overview of CJC-1295 and ipamorelin — how these two growth-hormone secretagogue peptides differ and why they are studied together in endocrinology.

CJC-1295 and ipamorelin recur together in endocrinology research on the somatotropic axis. They act on different receptors, which is precisely why they are studied as a pair. Both are supplied strictly for laboratory research use only and are not for human or veterinary use.

What CJC-1295 (DAC) is

CJC-1295 is a synthetic analogue of growth-hormone-releasing hormone (GHRH). The "DAC" designation refers to a Drug Affinity Complex modification that extends the molecule's circulating half-life in research models by binding to serum albumin. It is studied for its interaction with GHRH receptors and the somatotropic axis. Full profile: CJC-1295 research overview.

What ipamorelin is

Ipamorelin is a selective growth-hormone secretagogue and ghrelin-receptor (GHS-R) agonist, studied on the ghrelin-receptor arm of the somatotropic axis. It is supplied as a research blend with CJC-1295: Ipamorelin + CJC-1295 overview.

Why they are studied together

The two act on complementary points of the somatotropic axis, which is why endocrinology research often examines them in combination. The paired record is the Ipamorelin + CJC-1295 (10mg) blend.

Verifying identity and purity

Each batch carries a Certificate of Analysis with HPLC purity data. See analytical testing and certificates of analysis.

Research use

This overview is for laboratory research contexts only. It is not medical advice, and the compounds referenced are not for human or veterinary use.

Selected research literature

  1. Raun K, et al. (1998). Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. PMID 9849822
  2. Teichman SL, et al. (2005). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. PMID 16352683

These links point to published studies and do not constitute a health claim about any product.

Keep moving

Use Guides for the broader documentation model, Research Notes for catalog-adjacent commentary, and the catalog when you need the live product record or current ordering status.

Return to guides

Related reading

Published East Coast Labs notes stay connected to the storefront.

These notes stay reachable from Guides and Research Notes so updates, support pages, and catalog interpretation remain part of one public reading layer.

Research notes

Endogenous Peptides and Their Synthetic Analogs in Research

How many research peptides derive from naturally occurring molecules — mapping synthetic analogs and fragments like Semax, Selank, TB-500, and CJC-1295 to their parents.

Research notes

Melanocortin-System Research Peptides: KPV in Context

A factual look at KPV, a melanocortin-derived tripeptide, and how melanocortin-system peptides are studied in inflammation and receptor-pharmacology research.

Research notes

Growth-Hormone-Axis Research Peptides: GHRH Analogs and Secretagogues

An overview of research peptides studied on the growth-hormone/somatotropic axis — GHRH analogs, ghrelin-receptor secretagogues, and recombinant HGH as a reference protein.